• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-203在胆管癌中的预后意义

Prognostic significance of microRNA-203 in cholangiocarcinoma.

作者信息

Li Jingjing, Gao Beibei, Huang Zufa, Duan Tong, Li Daiqiang, Zhang Sheng, Zhao Yujun, Liu Lian, Wang Qiang, Chen Zhizhao, Cheng Ke

机构信息

Department of Pathology, Xiangya Basic Medical College, Central South University Changsha 410013, China.

Department of Pathology, The Second Xiangya Hospital of Central South University Changsha 410013, China.

出版信息

Int J Clin Exp Pathol. 2015 Aug 1;8(8):9512-6. eCollection 2015.

PMID:26464713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4583945/
Abstract

MircroRNA functions as a tumor suppressor or a promoter in cholangiocarcinoma (CCA). Researchers have found that miR-203 functioned as tumor suppressor in many types of cancer. However, the role of miR-203 that plays in CCA remains to be clarified. We aimed to detect the expression level and the prognostic significance of miR-203 in CCA tissues. qRT-RCR was performed to examine the miR-203 expression levels in CCA tissue specimens and corresponding normal tissues. Our findings suggest that miR-203 expression was an independent poor prognostic factor for CCA patient overall survival. Therefore, miR-203 may serve as a valuable prognostic marker and promising treatment target for CCA.

摘要

微小RNA在胆管癌(CCA)中起着肿瘤抑制因子或促进因子的作用。研究人员发现,miR-203在多种癌症中发挥肿瘤抑制作用。然而,miR-203在CCA中所起的作用仍有待阐明。我们旨在检测miR-203在CCA组织中的表达水平及其预后意义。采用qRT-RCR检测CCA组织标本及相应正常组织中miR-203的表达水平。我们的研究结果表明,miR-203表达是CCA患者总生存的独立不良预后因素。因此,miR-203可能作为CCA的一个有价值的预后标志物和有前景的治疗靶点。

相似文献

1
Prognostic significance of microRNA-203 in cholangiocarcinoma.微小RNA-203在胆管癌中的预后意义
Int J Clin Exp Pathol. 2015 Aug 1;8(8):9512-6. eCollection 2015.
2
MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.微小RNA-144通过靶向血小板活化因子乙酰水解酶1b亚型抑制胆管癌细胞的增殖和侵袭。
BMC Cancer. 2014 Dec 5;14:917. doi: 10.1186/1471-2407-14-917.
3
Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.下调的血液循环miR-150-5p作为胆管癌新型肿瘤标志物的分析
Tumour Biol. 2016 Nov;37(11):15019-15029. doi: 10.1007/s13277-016-5313-6. Epub 2016 Sep 22.
4
The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.SOCS3和A20在人类胆管癌中的预后作用
PLoS One. 2015 Oct 20;10(10):e0141165. doi: 10.1371/journal.pone.0141165. eCollection 2015.
5
SOX4 is associated with poor prognosis in cholangiocarcinoma.SOX4 与胆管癌的预后不良相关。
Biochem Biophys Res Commun. 2014 Sep 26;452(3):614-21. doi: 10.1016/j.bbrc.2014.08.124. Epub 2014 Aug 30.
6
Ars2 is overexpressed in human cholangiocarcinomas and its depletion increases PTEN and PDCD4 by decreasing microRNA-21.Ars2 在人类胆管癌中过表达,其通过降低 microRNA-21 来增加 PTEN 和 PDCD4 的表达。
Mol Carcinog. 2013 Apr;52(4):286-96. doi: 10.1002/mc.21859. Epub 2011 Dec 28.
7
Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.肝吸虫相关胆管癌患者循环miR-192:一项前瞻性预后指标
J Hepatobiliary Pancreat Sci. 2014 Dec;21(12):864-72. doi: 10.1002/jhbp.145. Epub 2014 Aug 12.
8
Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells.Sirtuin7 通过促进胆管癌细胞的生长而具有致癌潜能。
Biomed Pharmacother. 2018 Apr;100:257-266. doi: 10.1016/j.biopha.2018.02.007. Epub 2018 Feb 16.
9
A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.基于 RNA-Seq 数据的新型三 miRNA 标志物预测胆管癌患者的生存情况。
Oncol Rep. 2018 Sep;40(3):1422-1434. doi: 10.3892/or.2018.6534. Epub 2018 Jun 27.
10
Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.甲基化 CpG 结合蛋白 MBD2 参与了肝门部胆管癌中甲基化介导的 miR-373 抑制。
Oncol Rep. 2011 Feb;25(2):443-51. doi: 10.3892/or.2010.1089. Epub 2010 Dec 9.

引用本文的文献

1
The Role of microRNAs in Cholangiocarcinoma.微小 RNA 在胆管癌中的作用。
Int J Mol Sci. 2021 Jul 16;22(14):7627. doi: 10.3390/ijms22147627.
2
MicroRNA-1182 and let-7a exert synergistic inhibition on invasion, migration and autophagy of cholangiocarcinoma cells through down-regulation of NUAK1.微小RNA-1182和let-7a通过下调NUAK1对胆管癌细胞的侵袭、迁移和自噬发挥协同抑制作用。
Cancer Cell Int. 2021 Mar 9;21(1):161. doi: 10.1186/s12935-021-01797-z.
3
Aspirin inhibits cholangiocarcinoma cell proliferation via cell cycle arrest in vitro and in vivo.阿司匹林通过体外和体内细胞周期阻滞抑制胆管癌细胞增殖。
Int J Oncol. 2021 Feb;58(2):199-210. doi: 10.3892/ijo.2020.5165. Epub 2020 Dec 30.
4
Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.长链非编码 RNA NNT-AS1 通过下调 miR-203 促进胆管癌细胞增殖和上皮-间充质转化。
Aging (Albany NY). 2020 Feb 5;12(3):2333-2346. doi: 10.18632/aging.102747.
5
Diagnostic and prognostic value of microRNAs in cholangiocarcinoma: a systematic review and meta-analysis.微小RNA在胆管癌中的诊断和预后价值:一项系统评价和荟萃分析
Cancer Manag Res. 2018 Jul 18;10:2125-2139. doi: 10.2147/CMAR.S158155. eCollection 2018.
6
miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6.miR-223-3p 通过直接靶向 CDH6 抑制人骨肉瘤转移和进展。
Mol Ther. 2018 May 2;26(5):1299-1312. doi: 10.1016/j.ymthe.2018.03.009. Epub 2018 Mar 14.
7
miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA).微小RNA(miRNA)和长链非编码RNA(lncRNA)作为胆管癌(CCA)的生物标志物
Oncotarget. 2017 Jul 6;8(59):100819-100830. doi: 10.18632/oncotarget.19044. eCollection 2017 Nov 21.
8
Targeting Angiogenesis in Biliary Tract Cancers: An Open Option.靶向胆管癌血管生成:一种可行选择。
Int J Mol Sci. 2017 Feb 15;18(2):418. doi: 10.3390/ijms18020418.
9
MicroRNA-203 predicts human survival after resection of colorectal liver metastasis.微小RNA-203可预测结直肠癌肝转移切除术后的人类生存情况。
Oncotarget. 2017 Mar 21;8(12):18821-18831. doi: 10.18632/oncotarget.13816.

本文引用的文献

1
Prognostic significance and anti-proliferation effect of microRNA-365 in hepatocellular carcinoma.微小RNA-365在肝细胞癌中的预后意义及抗增殖作用
Int J Clin Exp Pathol. 2015 Feb 1;8(2):1705-11. eCollection 2015.
2
MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.微小RNA-21通过靶向蛋白酪氨酸磷酸酶非受体型14和磷酸酶及张力蛋白同源物在体外和体内促进肝内胆管癌的增殖和生长。
Oncotarget. 2015 Mar 20;6(8):5932-46. doi: 10.18632/oncotarget.3465.
3
Decreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinoma.在胆管癌中,组织因子途径抑制物-2(TFPI-2)表达降低与CD133表达增加相关。
Int J Clin Exp Pathol. 2015 Jan 1;8(1):328-36. eCollection 2015.
4
MicroRNA-195 functions as a tumor suppressor by inhibiting CBX4 in hepatocellular carcinoma.微小RNA-195在肝细胞癌中通过抑制CBX4发挥肿瘤抑制作用。
Oncol Rep. 2015 Mar;33(3):1115-22. doi: 10.3892/or.2015.3734. Epub 2015 Jan 19.
5
miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.微小RNA-203通过靶向胸苷酸合成酶增强结直肠癌对5-氟尿嘧啶的化疗敏感性。
Oncol Rep. 2015 Feb;33(2):607-14. doi: 10.3892/or.2014.3646. Epub 2014 Dec 4.
6
MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.微小RNA-144通过靶向血小板活化因子乙酰水解酶1b亚型抑制胆管癌细胞的增殖和侵袭。
BMC Cancer. 2014 Dec 5;14:917. doi: 10.1186/1471-2407-14-917.
7
MiR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1.微小RNA-203通过靶向多梳蛋白家族基因BMI1抑制黑色素瘤的侵袭和增殖能力。
Biochem Biophys Res Commun. 2015 Jan 2;456(1):361-6. doi: 10.1016/j.bbrc.2014.11.087. Epub 2014 Dec 2.
8
Autophagy may promote carcinoma cell invasion and correlate with poor prognosis in cholangiocarcinoma.自噬可能促进胆管癌细胞侵袭,并与胆管癌的不良预后相关。
Int J Clin Exp Pathol. 2014 Jul 15;7(8):4913-21. eCollection 2014.
9
miR-203 inhibits cell proliferation and migration of lung cancer cells by targeting PKCα.miR-203 通过靶向 PKCα 抑制肺癌细胞的增殖和迁移。
PLoS One. 2013 Sep 10;8(9):e73985. doi: 10.1371/journal.pone.0073985. eCollection 2013.
10
The expression and function of microRNA-203 in lung cancer.微小RNA-203在肺癌中的表达及功能
Tumour Biol. 2013 Feb;34(1):349-57. doi: 10.1007/s13277-012-0556-3. Epub 2012 Oct 17.